Martha Morrell - Aug 20, 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Leah Akin, Attorney-in-Fact
Stock symbol
NPCE
Transactions as of
Aug 20, 2025
Transactions value $
-$26,430
Form type
4
Date filed
8/22/2025, 04:15 PM
Previous filing
Jun 6, 2025
Next filing
Aug 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morrell Martha CHIEF MEDICAL OFFICER C/O NEUROPACE INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW /s/ Leah Akin, Attorney-in-Fact 2025-08-22 0001855616

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Tax liability -$26.4K -3.05K -3.46% $8.66 85.2K Aug 20, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer on August 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
F2 Includes 2,283 shares acquired pursuant to the NeuroPace, Inc. 2021 Employee Stock Purchase Plan.